These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9075138)

  • 1. In vitro biocompatibility evaluation of a novel bicarbonate-buffered amino-acid solution for peritoneal dialysis.
    Jörres A; Gahl GM; Ludat K; Frei U; Passlick-Deetjen J
    Nephrol Dial Transplant; 1997 Mar; 12(3):543-9. PubMed ID: 9075138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
    Plum J; Schoenicke G; Grabensee B
    Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions.
    Jörres A; Gahl GM; Topley N; Neubauer A; Ludat K; Müller C; Passlick-Deetjen J
    Nephrol Dial Transplant; 1994; 9(7):785-90. PubMed ID: 7970120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.
    Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ
    Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations.
    Plum J; Fusshöller A; Schoenicke G; Busch T; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
    Nephrol Dial Transplant; 1997 Aug; 12(8):1652-60. PubMed ID: 9269644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function.
    Jörres A; Bender TO; Finn A; Witowski J; Fröhlich S; Gahl GM; Frei U; Keck H; Passlick-Deetjen J
    Kidney Int; 1998 Dec; 54(6):2184-93. PubMed ID: 9853285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; Faict D; Gericke M; Lameire N; De Vriese A
    Nephron Exp Nephrol; 2005; 101(4):e139-45. PubMed ID: 16131808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility of a bicarbonate/lactate-buffered PD fluid tested with a double-chamber cell culture system.
    Fusshoeller A; Baehr J; Grabensee B; Plum J
    Perit Dial Int; 2005; 25(4):387-93. PubMed ID: 16022097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro.
    Cendoroglo M; Sundaram S; Jaber BL; Pereira BJ
    Am J Kidney Dis; 1998 Feb; 31(2):273-82. PubMed ID: 9469498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion.
    MacKenzie RK; Holmes CJ; Moseley A; Jenkins JP; Williams JD; Coles GA; Faict D; Topley N
    J Am Soc Nephrol; 1998 Aug; 9(8):1499-506. PubMed ID: 9697673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility of a bicarbonate-buffered amino-acid-based solution for peritoneal dialysis.
    Bender TO; Witowski J; Aufricht C; Endemann M; Frei U; Passlick-Deetjen J; Jörres A
    Pediatr Nephrol; 2008 Sep; 23(9):1537-43. PubMed ID: 18481110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
    Fusshoeller A; Plail M; Grabensee B; Plum J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions.
    Topley N
    Perit Dial Int; 1997; 17(1):42-7. PubMed ID: 9068021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes.
    Plum J; Lordnejad MR; Grabensee B
    Kidney Int; 1998 Jul; 54(1):224-35. PubMed ID: 9648083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function.
    Topley N; Kaur D; Petersen MM; Jörres A; Passlick-Deetjen J; Coles GA; Williams JD
    Kidney Int; 1996 May; 49(5):1447-56. PubMed ID: 8731113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.
    Topley N; Kaur D; Petersen MM; Jörres A; Williams JD; Faict D; Holmes CJ
    J Am Soc Nephrol; 1996 Feb; 7(2):218-24. PubMed ID: 8785390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced glucose degradation products in bicarbonate/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags.
    Cooker LA; Luneburg P; Faict D; Choo C; Holmes CJ
    Perit Dial Int; 1997; 17(4):373-8. PubMed ID: 9284465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.